Metformin Decreases Food Consumption and Induces Weight Loss in Subjects with Obesity with Type II Non‐Insulin‐Dependent Diabetes
Open accessAbstract
Metformin often promotes weight loss in patients with obesity with non‐insulin‐dependent diabetes mellitus (NIDDM). The mechanism may be attributed to decreased food intake. This study has tested the effect of metformin on satiety and its efficacy in inducing weight loss. Twelve diet‐treated NIDDM women with obesity were randomly given two dose levels (850 mg or 1700 mg) of metformin or placebo at 0800 for three consecutive days followed by a meal test on the third day on three occasions using a 3times3 Latin square design. The number of sandwich canapes eaten in three consecutive 10‐minute periods beginning at 1400 hours was used to quantitate food intake, and the level of subjective hunger was rated just before the sandwich meal with a linear analogue hunger rating scale at 1400 after a 6‐hour fast. The prior administration of metformin produced a reduction in calorie intake after each of the two doses of metformin treatment. The 1700‐mg metformin dose had the most marked appetite suppressant action. Similarly, hunger ratings were significantly lowered after metformin, and the effect was most pronounced after the administration of 1700 mg of metformin. To assess the efficacy of metformin in reducing bodyweight, 48 diet‐treated NIDDM women with obesity who had failed to lose weight by diet therapy were first placed on a 1200‐kcal ADA (American Diabetes Association) diet before being randomized to receive either metformin (850 mg) or placebo twice daily in a double‐blind fashion for 24 weeks. A 4‐week single‐blind placebo lead‐in period preceded and a 6‐week single‐blind placebo period followed the 24‐week double‐blind treatment period. Subjects treated with metformin continued to lose weight throughout 24 weeks of treatment; their mean maximum weight loss was 8 kg greater than that of the placebo group, with corresponding lower HbA1C and fasting blood glucose levels at the end of the active treatment period. These results indicate that metformin decreases calorie intake in a dose‐dependent manner and leads to a reduction in bodyweight in NIDDM patients with obesity.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Metformin supports weight loss by reducing food consumption.
“Furthermore, it supports weight loss344 by reducing food consumption.345”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [345]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419 · see citing works
Serum Immunoreactive-Leptin Concentrations in Normal-Weight and Obese Humans
Considine, R. V., Sinha, M. K., Heiman, M. L., Kriauciunas, A., Stephens, T. W., Nyce, M. R., Ohannesian, J. P., Marco, C. C., McKee, L. J., Bauer, T. L., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340503 · Cited by 6,326 · see citing works
Bailey, C. J., & Turner, R. C. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602293340906 · Cited by 1,726 · see citing works
The role of neuropeptide Y in the antiobesity action of the obese gene product
Stephens, T. W., Basinski, M., Bristow, P. K., Bue-Valleskey, J. M., Burgett, S. G., Craft, L., Hale, J., Hoffmann, J., Hsiung, H. M., Kriauciunas, A., et al. (1995) · Nature · doi:10.1038/377530a0 · Cited by 1,498 · see citing works
Metabolic effects of metformin in non-insulin-dependent diabetes mellitus
Stumvoll, M., Nurjhan, N., Perriello, G., Dailey, G., & Gerich, J. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508313330903 · Cited by 1,148 · see citing works
Hunger: Basic mechanisms and clinical implications
(1976) · Neuroscience · doi:10.1016/0306-4522(76)90139-1 · Cited by 917 · see citing works
Insulin in the Brain: A Hormonal Regulator of Energy Balance*
Schwartz, M. W., Figlewicz, D. P., Baskin, D. G., Woods, S. C., & Porte, D. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-3-387 · Cited by 808 · see citing works
Nestler, J. E., & Jakubowicz, D. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350902 · Cited by 743 · see citing works
Recent Advances in Obesity Research
Bray, G. A. (1979) · Cited by 610 · see citing works
Neuropeptide Regulation of Appetite and Weight*
Morley, J. E. (1987) · Endocrine Reviews · doi:10.1210/edrv-8-3-256 · Cited by 593 · see citing works
Self-citationBailey, C. J. (1992) · Diabetes Care · doi:10.2337/diacare.15.6.755 · Cited by 593 · see citing works
INTERNATIONAL TRIAL OF LONG-TERM DEXFENFLURAMINE IN OBESITY
Guy-grand, B., Crepaldi, G., Vre, P., Apfelbaum, M., Gries, A. F., & Turner, P. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91499-2 · Cited by 308 · see citing works
Pleasantness changes and food intake in a varied four-course meal
Rolls, B. J., Duijvenvoorde, P. M. V., & Rolls, E. T. (1984) · Appetite · doi:10.1016/s0195-6663(84)80006-9 · Cited by 293 · see citing works
Intraventricular insulin reduces food intake and body weight of lean but not obese zucker rats
Ikeda, H., West, D. B., Pustek, J. J., Figlewicz, D. P., Greenwood, M. R. C., Porte, D., & Woods, S. C. (1986) · Appetite · doi:10.1016/s0195-6663(86)80006-x · Cited by 230 · see citing works
Perriello, G., Misericordia, P., Volpi, E., Santucci, A., Santucci, C., Ferrannini, E., Ventura, M. M., Santeusanio, F., Brunetti, P., & Bolli, G. B. (1994) · Diabetes · doi:10.2337/diab.43.7.920 · Cited by 227 · see citing works
Weintraub, M. (1984) · Archives of Internal Medicine · doi:10.1001/archinte.144.6.1143 · Cited by 217 · see citing works
Metformin: a review of its pharmacological properties and therapeutic use.
Ls, H. (1979) · PubMed · Cited by 175 · see citing works
Thompson, D. A., & Campbell, R. G. (1977) · Science · doi:10.1126/science.929188 · Cited by 170 · see citing works
Insulin binding to brain capillaries is reduced in genetically obese, hyperinsulinemic Zucker rats
Schwartz, M. W., Lattemann, D. F., Kahn, S. E., Baskin, D. G., Greenwood, M. R. C., & Porte, D. (1990) · Peptides · doi:10.1016/0196-9781(90)90044-6 · Cited by 117 · see citing works
A Quadratic Equation Adequately Describes the Cumulative Food Intake Curve in Man
Kissileff, H. R., Thornton, J. C., & Becker, E. E. (1982) · Appetite · doi:10.1016/s0195-6663(82)80022-6 · Cited by 111 · see citing works
The role of glucose, insulin and glucagon in the regulation of food intake and body weight
Grossman, S. P. (1986) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(86)90015-1 · Cited by 109 · see citing works
Oral antidiabetic combination therapy with sulphonylureas and metformin.
Haupt, E., Knick, B., Koschinsky, T., Liebermeister, H., Schneider, J., & Hirche, H. (1991) · PubMed · Cited by 107 · see citing works
Clarke, B. F., & Duncan, L. J. P. (1968) · The Lancet · doi:10.1016/s0140-6736(68)92726-8 · Cited by 107 · see citing works
Clarke, B. F., & Campbell, I. W. (1977) · BMJ · doi:10.1136/bmj.2.6102.1576 · Cited by 89 · see citing works
THE ANORECTIC EFFECT OF DEXAMPHETAMINE SULPHATE
Silverstone, J. T., & Stunkard, A. J. (1968) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1968.tb00499.x · Cited by 78 · see citing works
Vagotomy and the Hunger-producing Action of Insulin in Man
Grossman, M. I., & Stein, I. F. (1948) · Journal of Applied Physiology · doi:10.1152/jappl.1948.1.4.263 · Cited by 69 · see citing works
Biguanide Treatment Increases the Number of Insulin-Receptor Sites on Human Erythrocytes
Holle, A., Mangels, W., Dreyer, M., Kühnau, J., & Rüdiger, H. W. (1981) · New England Journal of Medicine · doi:10.1056/nejm198109033051007 · Cited by 59 · see citing works
Effect of metformin on insulin receptor binding and glycaemic control in type II diabetes.
Lord, J. M., White, S. I., Bailey, C. J., Atkins, T. W., Fletcher, R. F., & Taylor, K. G. (1983) · BMJ · doi:10.1136/bmj.286.6368.830 · Cited by 46 · see citing works
Hermann, L. S., Karlsson, J. E., & Sj�strand, �. (1991) · European Journal of Clinical Pharmacology · doi:10.1007/bf00315441 · Cited by 39 · see citing works
A randomized double-blind clinical trial of fluoxetine in obese diabetics.
Gray, D. S., Fujioka, K., Devine, W., & Bray, G. A. (1992) · PubMed · Cited by 38 · see citing works
Weight-reducing Effect of Diguanides in Obese Non-diabetic Women
Munro, J., MacCuish, A. C., Marshall, A., Wilson, E. M., & Duncan, L. J. P. (1969) · BMJ · doi:10.1136/bmj.2.5648.13 · Cited by 32 · see citing works
Hermann, L. S., Bitzén, P. ‐., Kjellström, T., Lindgärde, F., & Scherstén, B. (1991) · PubMed · Cited by 25 · see citing works
Insulin Normalization as an Approach to the Pharmacological Treatment of Obesity
Campfield, L. A., Smith, F. J., Mackie, G., Tenenbaum, R., Sassano, M. L., Mullin, J., Kaiser, K., & Kierstead, R. W. (1995) · Obesity Research · doi:10.1002/j.1550-8528.1995.tb00231.x · Cited by 25 · see citing works
Papoz, L., Job, D., Eschwège, É., Aboulker, J.-P., Cubeau, J., Péquignot, G., Rathery, M., & Rosselin, G. (1978) · Diabetologia · doi:10.1007/bf01219646 · Cited by 24 · see citing works
Vigneri, R., Trischitta, V., Italia, S., Mazzarino, S., Rabuazzo, A. M., & Squatrito, S. (1991) · PubMed · Cited by 21 · see citing works
Energy expenditure in non-insulin dependent diabetic subjects on metformin or sulphonylurea therapy
Leslie, P. J., Jung, R. T., Isles, T. E., & Baty, J. D. (1987) · Clinical Science · doi:10.1042/cs0730041 · Cited by 21 · see citing works
McAlpine, L. G., McAlpine, C., Waclawski, E., Storer, A., Kay, J., & Frier, B. M. (1988) · European Journal of Clinical Pharmacology · doi:10.1007/bf00614548 · Cited by 20 · see citing works
Insulin Secretion in Hypothalamic Obesity: Diurnal Variation and the Effect of Naloxone
Lee, A. S., & Bray, G. A. (1993) · Obesity Research · doi:10.1002/j.1550-8528.1993.tb00027.x · Cited by 4 · see citing works
Self-citationTreatment of the obese diabetic patient.
Db, S. (1967) · PubMed · Cited by 4 · see citing works
Flagged first, then by citations
Research works printed but not linked: 8
- [2]2. Bailey CJ, Turner RC. Drug therapy: metformin. N Engl J Med. 1996;334:574-579.
- [18]18. Klein W. Sulfonylurea-metformin combination versus sulfo- nylurea-insulin-combination in secondary failures of sulfonyl- urea monotherapy. Diabetes Metab. 1991; 17:235-240.
- [19]19. Leatherdale BA, Bailey CJ. Acute antihyperglycemic effect of metformin without alteration of gastric emptying. IRCS Med Sci. 1986; 14: 1085-1086.
- [22]22. Lee A, Morley J. The effect of acarbose on body weight regulation. Diabetes. 1997;46:257A.
- [23]23. Lord JM, White SI, Bailey CJ, et al. Effect of metformin on insulin receptor binding and glycemic control in type I1 dia- betes. BMJ. 1983;286:830-83 l .
- [30]30. Rissanen A. Long-term weight management in obesity with 1988;34: 129-132. orlistat, a new gastrointestinal lipase inhibitor. Diubetes. 1997; 46:87A.
- [32]32. Schwartz MW, Finglewitz DP, Woods SC, Porte D Jr, et al. Insulin and the central regulation of energy balance: Up- date. Endocr Rev. 1992;13:387-414.
- [40]40. Weintraub M, Hasday JD, Mushlin AI, Lockwood D. Use of fenfluramine and phentermine alone and in combination. Arch Intern Med. 1984;144:1 143-1 148.
Cited by
Sorted by citations
Avenell, A., Broom, J., Brown, T., Poobalan, A., Aucott, L., Stearns, S., Smith, W., Jung, R., Campbell, M., & Grant, A. (2004) · Health Technology Assessment · doi:10.3310/hta8210 · Cited by 1,041 · see citing works
Pancreatic regulation of glucose homeostasis.
Röder, P. V., Wu, B., Liu, Y., & Han, W. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.6 · Cited by 985 · see citing works
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
Salpeter, S. R., Greyber, E., Pasternak, G. A., & Salpeter (posthumous), E. E. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002967.pub4 · Cited by 893 · see citing works
Cellular and Molecular Mechanisms of Metformin Action
LaMoia, T. E., & Shulman, G. I. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnaa023 · Cited by 791 · see citing works
Insulin‐associated weight gain in diabetes – causes, effects and coping strategies
Russell-Jones, D. L., & Khan, R. (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00686.x · Cited by 556 · see citing works
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
Salpeter, S. R., Greyber, E., Pasternak, G. A., & Salpeter, E. E. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002967.pub3 · Cited by 435 · see citing works
Metformin: Mechanisms in Human Obesity and Weight Loss
Yerevanian, A., & Soukas, A. A. (2019) · Current Obesity Reports · doi:10.1007/s13679-019-00335-3 · Cited by 414 · see citing works
Pathophysiology and Pharmacological Treatment of Insulin Resistance
Matthaei, S., Stümvoll, M., Kellerer, M., & Häring, H. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0413 · Cited by 372 · see citing works
Antipsychotic-associated weight gain: management strategies and impact on treatment adherence
Dayabandara, M., Hanwella, R., Ratnatunga, S. S., Seneviratne, S., Suraweera, C. U., & de Silva, V. A. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s113099 · Cited by 377 · see citing works
Energy Balance After Sodium–Glucose Cotransporter 2 Inhibition
Ferrannini, G., Hach, T., Crowe, S., Sanghvi, A., Hall, K. D., & Ferrannini, E. (2015) · Diabetes Care · doi:10.2337/dc15-0355 · Cited by 362 · see citing works
Metformin promotes lifespan through mitohormesis via the peroxiredoxin PRDX-2
De Haes, W., Frooninckx, L., Van Assche, R., Smolders, A., Depuydt, G., Billen, J., Braeckman, B. P., Schoofs, L., & Temmerman, L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321776111 · Cited by 355 · see citing works
Current and Potential Drugs for Treatment of Obesity
Bray, G. A., & Greenway, F. L. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0383 · Cited by 326 · see citing works
Mäkimattila, S., Nikkilä, K., & Yki‐Järvinen, H. (1999) · Diabetologia · doi:10.1007/s001250051172 · Cited by 313 · see citing works
Salpeter, S. R., Greyber, E., Pasternak, G. A., & Salpeter, E. E. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.21.2594 · Cited by 312 · see citing works
Day, E. A., Ford, R. J., Smith, B. K., Mohammadi-Shemirani, P., Morrow, M. R., Gutgesell, R. M., Lu, R., Raphenya, A. R., Kabiri, M., McArthur, A. G., et al. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0146-4 · Cited by 307 · see citing works
Metformin monotherapy for type 2 diabetes mellitus
Sáenz, A., Fernandez-Esteban, I., Mataix, A. L., Segura, M. A., Figuls, M. R. I., & Moher, D. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002966.pub3 · Cited by 304 · see citing works
RetractedMannucci, E., Ognibene, A., Cremasco, F., Bardini, G., Mencucci, A., Pierazzuoli, E., Ciani, S., Messeri, G., & Rotella, C. M. (2001) · Diabetes Care · doi:10.2337/diacare.24.3.489 · Cited by 300 · see citing works
Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin
Miles, J. M., Leiter, L., Hollander, P., Wadden, T., Anderson, J. W., Doyle, M., Foreyt, J., Aronne, L., & Klein, S. (2002) · Diabetes Care · doi:10.2337/diacare.25.7.1123 · Cited by 286 · see citing works
The Obesity Pandemic: Where Have We Been and Where Are We Going?
Roth, J., Qiang, X., Marbán, S. L., Redelt, H., & Lowell, B. (2004) · Obesity Research · doi:10.1038/oby.2004.273 · Cited by 264 · see citing works
Metformin attenuates Alzheimer’s disease-like neuropathology in obese, leptin-resistant mice
Li, J., Deng, J., Sheng, W., & Zuo, Z. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.03.002 · Cited by 260 · see citing works
Effectiveness of Metformin on Weight Loss in Non-Diabetic Individuals with Obesity
Seifarth, C., Schehler, B., & Schneider, H. (2012) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0032-1327734 · Cited by 258 · see citing works
Hanefeld, M., Brunetti, P., Schernthaner, G. H., Matthews, D. R., Charbonnel, B. H., & on behalf of the QUARTET Study Group (2004) · Diabetes Care · doi:10.2337/diacare.27.1.141 · Cited by 230 · see citing works
de Silva, V. A., Suraweera, C., Ratnatunga, S. S., Dayabandara, M., Wanniarachchi, N., & Hanwella, R. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-1049-5 · Cited by 227 · see citing works
Effects of metformin on weight loss: potential mechanisms
Malin, S. K., & Kashyap, S. R. (2014) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000095 · Cited by 223 · see citing works
Appetite regulation and weight control: the role of gut hormones
Perry, B., & Wang, Y. (2012) · Nutrition and Diabetes · doi:10.1038/nutd.2011.21 · Cited by 214 · see citing works
Golay, A. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803695 · Cited by 202 · see citing works
Effects of Metformin on Body Weight and Body Composition in Obese Insulin-Resistant Children
Yanovski, J. A., Krakoff, J., Salaita, C. G., McDuffie, J. R., Kozlosky, M., Sebring, N. G., Reynolds, J. C., Brady, S. M., & Calis, K. A. (2011) · Diabetes · doi:10.2337/db10-1185 · Cited by 193 · see citing works
Glueck, C. J., Fontaine, R. N., Wang, P., Subbiah, M. T. R., Weber, K., Illig, E., Streicher, P., Sieve-Smith, L., Tracy, T. M., Lang, J. E., et al. (2001) · Metabolism · doi:10.1053/meta.2001.24192 · Cited by 188 · see citing works
González, N., Prieto, I., del Puerto‐Nevado, L., Portal‐Núñez, S., Ardura, J. A., Cortón, M., Fernández‐Fernández, B., Aguilera, Ó., Gómez‐Guerrero, C., Mas, S., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14472 · Cited by 169 · see citing works
RSSDI-ESI clinical practice recommendations for the management of type 2 diabetes mellitus 2020
Madhu, S., Chawla, R., Makkar, B. M., Ghosh, S. K., Saboo, B., & Kalra, S. (2020) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_225_20 · Cited by 175 · see citing works
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
Salpeter, S. R., Greyber, E., Pasternak, G. A., & Salpeter, E. E. (2006) · The Cochrane Database of Systematic Reviews (Complete Reviews) · doi:10.1002/14651858.cd002967.pub2 · Cited by 163 · see citing works
Gökçel, A., Gümürdülü, Y., Karakose, H., Ertörer, M. E., Tanaci, N., Tütüncü, N. B., & Guvener, N. D. (2002) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2002.00181.x · Cited by 164 · see citing works
Lee, A., Patrick, P., Wishart, J., Horowitz, M., & Morley, J. E. (2002) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2002.00219.x · Cited by 150 · see citing works
Self-citationDiabetes medications and body weight
Mitri, J., & Hamdy, O. (2009) · Expert Opinion on Drug Safety · doi:10.1517/14740330903081725 · Cited by 136 · see citing works
Schweizer, A., Dejager, S., & Bosi, E. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01051.x · Cited by 126 · see citing works
RSSDI clinical practice recommendations for the management of type 2 diabetes mellitus 2017
Bajaj, S. (2018) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-018-0604-7 · Cited by 129 · see citing works
Strowig, S. M., Avilés-Santa, L. M., & Raskin, P. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1691 · Cited by 122 · see citing works
Lv, W., Wen, J., Li, L., Sun, R., Wang, J., Xian, Y., Cao, C., Wang, Y., & Gao, Y. (2012) · Brain Research · doi:10.1016/j.brainres.2012.01.028 · Cited by 118 · see citing works
Green, B. D., Irwin, N., Duffy, N. A., Gault, V. A., O'Harte, F. P. M., & Flatt, P. R. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.07.043 · Cited by 116 · see citing works
Chau-Van, C., Gamba, M., Salvi, R., Gaillard, R. C., & Pralong, F. P. (2006) · Endocrinology · doi:10.1210/en.2006-1237 · Cited by 115 · see citing works
Weight Effect of Current and Experimental Drugs for Diabetes Mellitus
Purnell, J. Q., & Weyer, C. (2003) · Treatments in Endocrinology · doi:10.2165/00024677-200302010-00004 · Cited by 113 · see citing works
Metformin as Treatment for Overweight and Obese Adults: A Systematic Review
Levri, K. M. (2005) · The Annals of Family Medicine · doi:10.1370/afm.343 · Cited by 104 · see citing works
Cheng, Y., Leu, H., Chen, T., Chen, C.-L., Kuo, C., Lee, S., & Kao, C.-L. (2013) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2013.09.001 · Cited by 104 · see citing works
Václavík, L., Krynitsky, A. J., & Rader, J. I. (2014) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-014-8159-z · Cited by 103 · see citing works
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
Salpeter, S. R., Greyber, E., Pasternak, G. A., & Salpeter, E. E. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002967 · Cited by 102 · see citing works
Glueck, C. J., Dharashivkar, S., Wang, P., Zhu, B., Gartside, P. S., Tracy, T., & Sieve, L. (2005) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2005.03.010 · Cited by 99 · see citing works
Mulligan, K. M., Yang, Y., Wininger, D. A., Koletar, S. L., Parker, R. A., Alston‐Smith, B., Schouten, J. T., Fielding, R. A., Basar, M. T., & Grinspoon, S. K. (2006) · AIDS · doi:10.1097/qad.0b013e328011220e · Cited by 99 · see citing works
INTENSIVE THERAPIES FOR PEDIATRIC OBESITY
Yanovski, J. A. (2001) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(05)70356-4 · Cited by 97 · see citing works
Type 2 diabetes mellitus incidence in Chinese: Contributions of overweight and obesity
Wang, C., Li, J., Xue, H., Li, Y., Huang, J., Mai, J., Chen, J., Cao, J., Wu, X., Guo, D., et al. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.09.059 · Cited by 91 · see citing works
Lactic Acidosis in Metformin Therapy
Lalau, J., & Race, J. (1999) · Drugs · doi:10.2165/00003495-199958001-00013 · Cited by 91 · see citing works
Allen, H. F., Mazzoni, C., Heptulla, R. A., Murray, M. A., Miller, N., Koenigs, L., & Reiter, E. O. (2005) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2005.18.8.761 · Cited by 90 · see citing works
Anorexia, Weight Loss, and Frailty
Morley, J. E. (2010) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2010.02.005 · Cited by 88 · see citing works
Self-citationZhang, S., Bruce, K., Danaei, Z., Li, R. J. W., Barros, D. R., Kuah, R., Lim, Y.-M., Mariani, L. H., Cherney, D. Z. I., Chiu, J. F. M., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.03.014 · Cited by 88 · see citing works
Metformin and feeding increase levels of the appetite-suppressing metabolite Lac-Phe in humans
Scott, B., Day, E. A., O’Brien, K., Scanlan, J., Cromwell, G. E., Scannail, A. N., McDonnell, M. E., Finlay, D. K., & Lynch, L. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01018-7 · Cited by 87 · see citing works
Mechanism of glucose-lowering by metformin in type 2 diabetes: Role of bile acids
Sansome, D. J., Xie, C., Veedfald, S., Horowitz, M., Rayner, C. K., & Wu, T. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13869 · Cited by 84 · see citing works
Lac-Phe mediates the effects of metformin on food intake and body weight
Xiao, S., Li, V. L., Lyu, X., Chen, X., Wei, W., Abbasi, F., Knowles, J. W., Tung, A. S.-H., Deng, S., Tiwari, G., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-00999-9 · Cited by 82 · see citing works
Skalicka‐Woźniak, K., Georgiev, M. I., & Orhan, İ. E. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.06.018 · Cited by 81 · see citing works
Modulation of Hunger by Plasma Glucose and Metformin
Schultes, B., Oltmanns, K. M., Kern, W., Fehm, H. L., Jan Born, A., & Peters, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021450 · Cited by 81 · see citing works
Anti-Diabetes and Anti-Obesity Medications: Effects on Weight in People With Diabetes
Hollander, P. A. (2007) · Diabetes Spectrum · doi:10.2337/diaspect.20.3.159 · Cited by 81 · see citing works
Szymczak-Pajor, I., Wenclewska, S., & Śliwińska, A. (2022) · Pharmaceuticals · doi:10.3390/ph15070810 · Cited by 81 · see citing works
Fiedorowicz, J. G., Miller, D. D., Bishop, J. R., Calarge, C. A., Ellingrod, V. L., & Haynes, W. G. (2012) · Current Psychiatry Reviews · doi:10.2174/157340012798994867 · Cited by 79 · see citing works
Chronic activation of AMP-activated kinase as a strategy for slowing aging
McCarty, M. F. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.01.043 · Cited by 77 · see citing works
Maniar, K., Moideen, A., Mittal, A., Patil, A., Chakrabarti, A., & Banerjee, D. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.12.003 · Cited by 75 · see citing works
Weight Management for Type 2 Diabetes Mellitus: Global Cardiovascular Risk Reduction
Lee, M., & Aronne, L. J. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.11.007 · Cited by 73 · see citing works
Involvement of glucagon‐like peptide‐1 in the glucose‐lowering effect of metformin
Bahne, E., Hansen, M., Brønden, A., Sonne, D. P., Vilsbøll, T., & Knop, F. K. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12697 · Cited by 72 · see citing works
Matsui, Y., Hirasawa, Y., Sugiura, T., Toyoshi, T., Kyuki, K., & Ito, M. (2010) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.33.963 · Cited by 71 · see citing works
The Effects of Metformin and Diet on Plasma Testosterone and Leptin Levels in Obese Men
Özata, M., Öktenli, Ç., Bingöl, N., & Ozdemír, I. C. (2001) · Obesity Research · doi:10.1038/oby.2001.90 · Cited by 71 · see citing works
The Mechanism of Action of Biguanides: New Answers to a Complex Question
Magno, L. D., Pastena, F. D., Bordone, R., Coni, S., & Canettieri, G. (2022) · Cancers · doi:10.3390/cancers14133220 · Cited by 75 · see citing works
Update on diabetes in the elderly and in nursing home residents
Migdal, A., Yarandi, S. S., Smiley, D., & Umpierrez, G. E. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.02.010 · Cited by 81 · see citing works
An overview of diabetes mellitus in older persons.
Morley, J. E. (1999) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(18)30055-7 · Cited by 84 · see citing works
Self-citationLiu, L., Simon, B., Shi, J., Mallhi, A. K., & Eisen, H. J. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i18.449 · Cited by 67 · see citing works
Gondwe, M. M., Kamadyaapa, D. R., Tufts, M., Chuturgoon, A. A., & Musabayane, C. T. (2008) · Phytomedicine · doi:10.1016/j.phymed.2008.02.004 · Cited by 65 · see citing works
Clinical Management of Diabetes in the Elderly
Chau, D., & Edelman, S. V. (2001) · Clinical Diabetes · doi:10.2337/diaclin.19.4.172 · Cited by 64 · see citing works
Yasuda, N., Inoue, T., Nagakura, T., Yamazaki, K., Kira, K., Saeki, T., & Tanaka, I. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.064964 · Cited by 64 · see citing works
Anderson, J. J. A., Couper, J., Giles, L. C., Leggett, C., Gent, R. J., Coppin, B., & Peña, A. S. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00781 · Cited by 64 · see citing works
Fung, C. S. C., Wan, E. Y. F., Wong, C. K. H., Jiao, F., & Chan, A. K. C. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0304-2 · Cited by 62 · see citing works
Strategies to counter antipsychotic-associated weight gain in patients with schizophrenia
Marteene, W., Winckel, K., Hollingworth, S., Kisely, S. R., Gallagher, E., Hahn, M., Ebdrup, B. H., Firth, J., & Siskind, D. J. (2019) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2019.1674809 · Cited by 62 · see citing works
Gu, S., Shi, J., Tang, Z., Sawhney, M. S., Hu, H., Shi, L., Fonseca, V. A., & Dong, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126704 · Cited by 62 · see citing works
Effects of metformin on energy intake and satiety in obese children
Adeyemo, M. A., McDuffie, J. R., Kozlosky, M., Krakoff, J. A., Calis, K. A., Brady, S. M., & Yanovski, J. A. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12426 · Cited by 61 · see citing works
Widjajakusuma, E. C., Jonosewojo, A., Hendriati, L., Wijaya, S., Ferawati, Adrianta, S., Sastrowardoyo, W., Monita, N., Muna, N. M., Fajarwati, R. P., et al. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.07.002 · Cited by 60 · see citing works
Ziqubu, K., Mazibuko-Mbeje, S. E., Mthembu, S. X. H., Mabhida, S. E., Jack, B. U., Nyambuya, T. M., Nkambule, B. B., Basson, A. K., Tiano, L., & Dludla, P. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032227 · Cited by 64 · see citing works
Metformin: A Dual-Role Player in Cancer Treatment and Prevention
Galal, M. A., Al-Rimawi, M., Hajeer, A., Dahman, H., Alouch, S. S., & Aljada, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25074083 · Cited by 68 · see citing works
Yaturu, S. (2011) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2011.14012 · Cited by 59 · see citing works
Meng, H., Zhang, A., Liang, Y., Hao, J., Zhang, X., & Lu, J. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2983 · Cited by 56 · see citing works
Inhibitory G proteins and their receptors: emerging therapeutic targets for obesity and diabetes
Kimple, M. E., Neuman, J. C., Linnemann, A. K., & Casey, P. J. (2014) · Experimental & Molecular Medicine · doi:10.1038/emm.2014.40 · Cited by 54 · see citing works
Update on Diabetes in the Elderly and the Application of Current Therapeutics
Mazza, A. D., & Morley, J. E. (2007) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2007.07.007 · Cited by 55 · see citing works
Self-citationPournaghi, P., Sadrkhanlou, R., Hasanzadeh, S., & Foroughi, A. (2012) · Europe PMC (PubMed Central) · Cited by 54 · see citing works
Małecki, M. T., Batterham, R. L., Sattar, N., Levine, J. A., Rodríguez, Á., Bergman, B. K., Wang, H., Ghimpeteanu, G., & Lee, C. J. (2023) · Diabetes Care · doi:10.2337/dc23-1135 · Cited by 52 · see citing works
Wu, T., Ma, J., Bound, M. J., Checklin, H. L., Deacon, C. F., Jones, K. L., Horowitz, M., & Rayner, C. K. (2014) · Diabetes · doi:10.2337/db13-1627 · Cited by 52 · see citing works
Metformin Use in Children and Adolescents with Prediabetes.
Khokhar, A., Umpaichitra, V., Chin, V. L., & Perez-Colon, S. (2017) · The Pediatric clinics of North America · doi:10.1016/j.pcl.2017.08.010 · Cited by 51 · see citing works
Stevanović, D., Janjetović, K., Misirkic-Marjanovic, M., Vucicevic, L. M., Šumarac-Dumanović, M., Micić, D., Starcevic, V. P., & Trajković, V. (2012) · Neuroendocrinology · doi:10.1159/000333963 · Cited by 52 · see citing works
Ellul, P., Delorme, R., & Cortese, S. (2018) · CNS Drugs · doi:10.1007/s40263-018-0571-z · Cited by 51 · see citing works
Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs
Koopmans, S. J., Mroz, Z., Dekker, R. A., Corbijn, H., Ackermans, M. T., & Sauerwein, H. P. (2006) · Metabolism · doi:10.1016/j.metabol.2006.03.004 · Cited by 51 · see citing works
Tratamento Farmacológico da Obesidade
Mancini, M. C., & Halpern, A. (2002) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302002000500003 · Cited by 49 · see citing works
Hertzer, K. M., Xu, M., Moro, A., Dawson, D. W., Du, L., Li, G., Chang, H.-H., Stark, A. P., Jung, X., Hines, O. J., et al. (2015) · Pancreas · doi:10.1097/mpa.0000000000000497 · Cited by 50 · see citing works
Li, Y., Tan, J., Wang, Q., Duan, C., Hu, Y., & Huang, W. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2019.09.011 · Cited by 50 · see citing works
Reconsidering repurposing: long-term metformin treatment impairs cognition in Alzheimer’s model mice
Cho, S. Y., Kim, E. W., Park, S. J., Phillips, B. U., Jeong, J., Kim, H., Heath, C. J., Kim, D., Jang, Y., López‐Cruz, L., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02755-9 · Cited by 49 · see citing works
Feinglos, M. N., DAILEY, G. E., Cefalu, W. T., Osei, K., Tayek, J. A., Canovatchel, W. J., Chaiken, R. L., & KOURIDES, I. A. (2004) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.09.002 · Cited by 48 · see citing works
Medications as Adjunct Therapy for Weight Loss: Approved and Off-Label Agents in Use
Moyers, S. B. (2005) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2005.03.010 · Cited by 47 · see citing works
Management approaches for pediatric obesity
Miller, J. L., & Silverstein, J. H. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0669 · Cited by 44 · see citing works
- Authors
- Lee, A., & Morley, J. E.
- Affiliations
- Saint Louis University (US)
- Corresponding author
- Lee, Amy
- Venue
- Obesity Research
- Publisher
- Wiley
- Published
- 1998-01
- Volume
- 6
- Issue
- 1
- Pages
- 47-53
- ISSN
- 1071-7323 (ISSN-L)
- 1550-8528
- OpenAlex
- W2092252523
- Cited by
- 320
- References
- 40
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 12 · 2023: 14 · 2022: 14 · 2021: 10 · 2020: 12 · 2019: 12 · 2018: 14 · 2017: 19 · 2016: 15 · 2015: 10 · 2014: 22 · 2013: 12 · 2012: 15
- FWCI
- 5.13
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Obesity Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology › Pharmacology and Obesity Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- metformin, obesity, type 2 diabetes, weight loss, dietary intake, satiety, appetite suppression, hunger, dose-dependent effects, dietary therapy, glycemic control, HbA1c, fasting blood glucose
- MeSH terms
- Adult, Blood Glucose, Energy Intake, Diabetes Mellitus, Diabetes Mellitus, Type 2, Double-Blind Method, Eating, Female, Glycated Hemoglobin, Humans, Hunger, Hypoglycemic Agents, Metformin, Middle Aged, Obesity, Weight Loss
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
